日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Position statement on the management of pregnancy in sickle cell disease

关于镰状细胞病妊娠管理的立场声明

Yue, Mimi; Mason, Kylie; Rowlands, Shelley; Kaplan, Zane; Kennedy, Debra; Kidson-Gerber, Giselle

Economic burden of sickle cell disease in Australia

澳大利亚镰状细胞病带来的经济负担

Nwokeocha, Steve; Haysom, Helen E; Wellard, Cameron; Roberts, Tracy; Kachapila, Mwayi; Chee, Melissa; Petrie, Dennis; McQuilten, Zoe K; Waters, Neil; Greenway, Anthea; Mason, Kylie; Nelson, Anna; Kaplan, Zane; Ho, P Joy; Wood, Erica M; Irving, Adam

Management of hairy cell leukaemia in pregnancy

妊娠期毛细胞白血病的治疗

Da Cruz, Simone; Mason, Kylie; Renwick, William; Said, Joanne M; Cutts, Briony A

Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study

利妥昔单抗-甲氨蝶呤、卡莫司汀、替尼泊苷和泼尼松龙治疗原发性中枢神经系统淋巴瘤后的生存率、神经认知功能和健康相关生活质量结局:HOVON 105/ALLG NHL 24 研究的最终结果

Bromberg, Jacoline E C; Issa, Samar; van der Holt, Bronno; van der Meulen, Matthijs; Dirven, Linda; Minnema, Monique C; Seute, Tatjana; Durian, Marc; Cull, Gavin; van der Poel, Marjolein W M; Stevens, Wendy B C; Zijlstra, Josee M; Brandsma, Dieta; Nijland, Marcel; Mason, Kylie D; Beeker, Aart; Abrahamse-Testroote, Martine C J; van den Bent, Martin J; de Jong, Daphne; Doorduijn, Jeanette K

Thrombosis in patients with immune thrombocytopenia: incidence, risk, and clinical outcomes

免疫性血小板减少症患者的血栓形成:发生率、风险和临床结局

Goncalves, Isaac; Lewis, Cameron; Grainger, Brian; Dring, Rebecca; Lee, Nora; Pasricha, Sant-Rayn; Szer, Jeffrey; Mason, Kylie

Experiences of cohabiting partners of women diagnosed with cancer during pregnancy: a qualitative study

妊娠期癌症患者同居伴侣的经历:一项定性研究

Sinclair, Michelle; Song, Richard; Peate, Michelle; Saunders, Christobel; Lippey, Jocelyn; Umstad, Mark P; Mason, Kylie; Ives, Angela; Stafford, Lesley

Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trials

阿伐曲波帕联合免疫抑制疗法治疗初治和复发/难治性重型再生障碍性贫血的疗效和安全性:DIAAMOND-Ava-FIRST 和 DIAAMOND-Ava-NEXT 贝叶斯最优 II 期试验方案

McQuilten, Zoe; Heritier, Stephane; Fox, Lucy; Fox, Vanessa; Young, Lauren; Blombery, Piers; Cunningham, Ilona; Curnow, Jennifer; Higgins, Alisa; Hiwase, Devendra K; Filshie, Robin; Firkin, Frank; Lacaze, Paul; Mason, Kylie; Mills, Anthony K; Pepperell, Dominic; Patil, Sushrut; Stevenson, William; Szer, Jeff; Waters, Neil; Wilson, Kate; Ting, Stephen; Wood, Erica

CD34-TdT-B-ALL masquerading as Burkitt lymphoma

CD34-TdT-B-ALL 伪装成伯基特淋巴瘤

Juneja, Manu; Wei, Andrew; Mason, Kylie; Nguyen, Tamia; Seymour, John F; Juneja, Surender

Proinflammatory microenvironment promotes lymphoma progression in mice with high megakaryocyte and TPO levels

促炎微环境促进巨核细胞和TPO水平高的小鼠淋巴瘤进展

Au, Amanda E; Corbin, Jason; Lebois, Marion; Gangatirkar, Pradnya; Yassinson, Fatme; Hyslop, Stephanie R; Cannon, Ping; Mason, Kylie D; Li-Wai-Suen, Connie S N; Garnham, Alexandra L; Moujalled, Diane; Cimmino, Luisa; Alexander, Warren S; Josefsson, Emma C

OP138 Navigating High-Cost Medicines: Promoting Consistent, Evidence-based Use Of High-Cost Medicines In A Fiscally And Equitable Responsible Manner

OP138 驾驭高价药物:以财政公平负责的方式促进高价药物的持续、循证使用

Kotwani, Anita; Pulver, Lisa; Barclay, Peter; Bennett, Dr Sasha; Burgess, Naomi; Dartnell, Jonathan; Drake, Catherine; Laba, Tracey-Lea; Liew, David; Mason, Kylie; Melocco, Terry; O’Reilly, Mary; Sheahan, Linda; Subramaniam, Kavitha; Hill, Catherine